Compare
Abbott Laboratories vs CONMED (ABT vs CNMD)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Abbott Laboratories (ABT) returned -11.7% and CONMED (CNMD) +15.9%; so far this year the figures are -12.3% and +26.9%.
Abbott Laboratories is the larger company by market value, about 124.4 times the size of CONMED.
On trailing earnings, ABT trades at 40.9 times and CNMD at 34.1 times.
Revenue grew +10.0% at ABT and +5.2% at CNMD over the last year.
ABT yields 2.29%. CNMD pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| ABT | CNMD | |
|---|---|---|
| Price | $109.93 | $51.50 |
| 1-day | -3.23% | -2.52% |
| YTD | -12.26% | +26.85% |
| 1 year | -11.73% | +15.89% |
| 3 years | +15.70% | -47.83% |
| Market cap | $190.4B | $1.5B |
| P/E | 40.9 | 34.1 |
| P/S | 3.95 | 1.12 |
| P/B | 3.73 | 1.45 |
| Revenue growth | +10.00% | +5.20% |
| EPS growth | -66.20% | — |
| Gross margin % | 56.9 | 54.6 |
| Net margin % | 9.7 | 3.4 |
| ROE % | 9.2 | 4.4 |
| Debt / equity | 0.61 | 0.77 |
| FCF yield % | 3.5 | 9.8 |
| Dividend yield % | 2.29 | — |
| Beta | 0.06 | 0.78 |
| RSI (14) | 58.5 | 60.8 |
| Technical rating |